With the ever-increasing availability and clinical use of brain magnetic resonance imaging (MRI), the frequency of white matter hyperintensities (WMH) has become more readily apparent. As a heavy burden of WMH has been shown to be an important risk factor for incident stroke as well as vascular cognitive impairment, 1 it is important to understand the pathophysiology, etiology, and clinical implications of WMH volume.
Neuroimaging
WMH are demonstrated on T2-weighted MRI sequences. These damaged regions are evidenced on the T2 sequence as high signal intensity, which appear bright. 9 They are considered white matter lesions if hyperintense on T2-weighted, fluid-attenuated inversion recovery and proton density images, without prominent hypointensity on T1-weighted images. 1 They indicate areas of increased brain water content in white matter tissue, but the degree of damage to axons and supporting cells is not clear and remains an area under study (see Pathology below). 9 Recent evidence using diffusion tensor imaging has suggested a linear relationship between blood pressure levels and the microstructural integrity of both normal appearing white matter and white matter hyperintensities. In hypertensive patients, the microstructural integrity of the cerebral white matter is significantly more affected than in normotensive patients.
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Pathology of White Matter Hyperintensities
The most common areas affected by WMH are in the deep white matter of the cerebral hemispheres, especially in the distribution of end-arteries and arterioles that supply a border-zone territory with minimal irrigation by collateral vessels. In areas identified as hyperintensities on MRI, pathological studies have reported myelin pallor, loss of tissue density, myelin and axonal loss, and gliosis. 11, 12 These lesions are hypothesized to be caused by chronic hypoperfusion of the white matter due to low-grade vascular insufficiency resulting in ischemia, 12 and are often associated with structural changes of the vessels, including hyalinization, tortuosity, elongation, and narrowing with arteriosclerosis and lipohyalinosis. 12, 13 Many of these changes have been associated with hypertension. 23 however, the prevalence is much greater in those with a heavy burden of WMH.
In the current literature, there are seven notable population-based observational studies on the relationship between blood pressure and WMH burden, four of which were cross-sectional and three of which were longitudinal. All seven studies showed a significant association between elevated blood pressure and WMH burden, although methodologies and sample sizes varied across the studies, including the way WMH were measured and quantified. All seven studies utilized measured blood pressure levels rather than relying on self-reported hypertension. However, a limitation in the current literature is that most studies used a single measurement of blood pressure and therefore were not able to capture changes in blood pressure over time. Further, most studies examined hypertension as a dichotomous variable rather than examining blood pressure continuously that would have allowed for evaluation of a dose-response, and the majority of studies were conducted in homogeneous, predominantly Caucasian, older populations that limit generalizability to other populations.
In the Cardiovascular health study, 3,301 stroke-free participants over the age of 65 who had undergone MRI were evaluated. WMH burden was positively associated with systolic blood pressure, diastolic blood pressure and orthostatic hypotension, and the relationship was similar regardless of whether the WMH were more predominant in the periventricular, subcortical, or both regions. 3 The Framingham Heart study also evaluated 1,814 patients who were stroke-free as well as 
Effects of Anti-hypertensives on White Matter Hyperintensities
Studies The Atherosclerosis risk in communities (ARIC) study also evaluated WMH progression over 10 years in relation to blood pressure changes (n=1,920) and includes both black and white participants. This study demonstrated that cumulative systolic blood pressure was a strong predictor of WMH progression, and stronger than systolic blood pressure measured at any individual time point. This association was similar in both the black and white subjects. Interestingly, in the black subjects only, earlier (midlife) SBP measurements were stronger predictors of WMH progression than later measurements.
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Clinical Trials
To date, the only randomised controlled trial addressing blood pressure 
Implications for Stroke Prediction and Prevention
A recent meta-analysis showed that WMH are a risk factor for incident stroke. 1 Based on increasing evidence, some of which is presented above, blood pressure is increasingly recognized as perhaps the most important modifiable risk factor for the development of WMH. However, 
